Horizon Therapeutics (HZNP) PT Raised to $120 at Jefferies on VIE Transaction
Tweet Send to a Friend
Jefferies analyst David Steinberg raised the price target on Horizon Therapeutics (NASDAQ: HZNP) to $120.00 (from $103.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
